Trendlines sets up JV in Shanghai
Add BT as a preferred sourceTHE Trendlines Group on Monday announced that it has together with Chinese private equity firm Shoushan Wealth Holdings, set up China-Israel New Trend (Taizhou) Medical Technology.
The latter, which will be based in Shanghai, is a joint venture to help Trendlines' medical sector portfolio companies as well as other Israeli, Singaporean and other medical companies penetrate the Chinese market.
This includes helping companies establish manufacturing capabilities in China, obtain regulatory approval for the sale of products in China, and manage strategic partner relationships.
Trendlines and Shoushan also intend to raise venture funds (in US dollar and Chinese renminbi) to invest in global medical technology companies.
Trendlines is a Catalist-listed, Israeli and Singapore-based incubator that invests in and nurtures early-stage medical and agricultural technology companies.
Share with us your feedback on BT's products and services
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
Not retirement, but a rewiring and fresh perspectives post-DBS, says Piyush Gupta
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
Power of payouts: A big chunk of the STI has just gone ex-dividend. What’s next?
